A NEW MEDICATION-RELATED CUMULATIVE ANTICHOLINERGIC EXPOSURE INDEX EVALUATING RISK OF COGNITIVE IMPAIRMENT

Abstract

Given the associations between anticholinergic exposure and poor clinical outcomes in older adults, precise quantification of the cumulative anticholinergic burden appears advisable to evaluate the risk–benefit ratio of prescribing or deprescribing some medications.

The paper